LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for ACELYRIN, INC. and Millions of Other Companies

Sign up for full access to ACELYRIN, INC. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Clinical Trials Focus Acelyrin, Inc. is actively involved in developing new treatments for autoimmune diseases like hidradenitis suppurativa and psoriatic arthritis, providing an opportunity for sales of medical supplies or services catering to clinical trial operations.

Executive Changes With recent changes in key personnel like the appointment of a new CEO and the departure of a managing director, there may be potential sales opportunities for consulting services or executive recruitment firms to support organizational transitions.

Investment Influx Receiving significant investments such as $2.43 million from Vontobel Holding Ltd. and attracting new investments from ProFunds Distributors, Inc. indicates the company's growth potential, presenting sales opportunities for financial services or investment management solutions.

Legal Challenges Facing lawsuits from Glancy Prongay & Murray LLP and Robbins LLP suggests a need for legal services or risk management solutions, presenting potential sales opportunities in the legal sector to support the company's defense or settlement strategies.

Revenue Range & Funding With reported revenue between $10M - 50M and a funding amount of $300M, Acelyrin, Inc. demonstrates financial stability and growth prospects, providing opportunities for sales of business services, technology solutions, or other offerings to support their expanding operations.

Similar companies to ACELYRIN, INC.

✕

Access Insights for ACELYRIN, INC. and Millions of Other Companies

Sign up for full access to ACELYRIN, INC. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

ACELYRIN, INC. Tech Stack

ACELYRIN, INC. uses 8 technology products and services including SAS, Cloudinary, NetSuite, and more. Explore ACELYRIN, INC.'s tech stack below.

  • SAS
    Business Intelligence
  • Cloudinary
    Content Delivery Network
  • NetSuite
    E-commerce
  • Vue.js
    Javascript Frameworks
  • Acquia Cloud Platform
    Platform As A Service
  • Akamai Bot Manager
    Security
  • Adobe Creative Suite
    Visualisation Software
  • Acquia Cloud Site Factory
    Web Hosting

ACELYRIN, INC.'s Email Address Formats

ACELYRIN, INC. uses at least 1 format(s):
ACELYRIN, INC. Email FormatsExamplePercentage
First.Last@acelyrin.comJohn.Doe@acelyrin.com
97%
First@acelyrin.comJohn@acelyrin.com
2%
FLast@acelyrin.comJDoe@acelyrin.com
1%

Frequently Asked Questions

Where is ACELYRIN, INC.'s headquarters located?

Minus sign iconPlus sign iconACELYRIN, INC.'s main headquarters is located at 4149 Liberty Canyon Rd Agoura Hills, California 91301 US. The company has employees across 2 continents, including North AmericaOceania.

What is ACELYRIN, INC.'s stock symbol?

Minus sign iconPlus sign iconACELYRIN, INC. is a publicly traded company; the company's stock symbol is SLRN.

What is ACELYRIN, INC.'s official website and social media links?

Minus sign iconPlus sign iconACELYRIN, INC.'s official website is acelyrin.com and has social profiles on LinkedIn.

How much revenue does ACELYRIN, INC. generate?

Minus sign iconPlus sign icon As of September 2024, ACELYRIN, INC.'s annual revenue reached $15M.

What is ACELYRIN, INC.'s SIC code NAICS code?

Minus sign iconPlus sign iconACELYRIN, INC.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ACELYRIN, INC. have currently?

Minus sign iconPlus sign iconAs of September 2024, ACELYRIN, INC. has approximately 110 employees across 2 continents, including North AmericaOceania. Key team members include Chief Executive Officer And Board Member: M. K.Chief Technical Officer: P. T.Chief Operating Officer: M. G.. Explore ACELYRIN, INC.'s employee directory with LeadIQ.

What industry does ACELYRIN, INC. belong to?

Minus sign iconPlus sign iconACELYRIN, INC. operates in the Biotechnology Research industry.

What technology does ACELYRIN, INC. use?

Minus sign iconPlus sign iconACELYRIN, INC.'s tech stack includes SASCloudinaryNetSuiteVue.jsAcquia Cloud PlatformAkamai Bot ManagerAdobe Creative SuiteAcquia Cloud Site Factory.

What is ACELYRIN, INC.'s email format?

Minus sign iconPlus sign iconACELYRIN, INC.'s email format typically follows the pattern of . Find more ACELYRIN, INC. email formats with LeadIQ.

How much funding has ACELYRIN, INC. raised to date?

Minus sign iconPlus sign icon As of September 2024, ACELYRIN, INC. has raised $300M in funding. The last funding round occurred on Sep 13, 2022 for $300M.

When was ACELYRIN, INC. founded?

Minus sign iconPlus sign iconACELYRIN, INC. was founded in 2020.
ACELYRIN, INC.

ACELYRIN, INC.

Biotechnology ResearchCalifornia, United States51-200 Employees

ACELYRIN, INC.  (Nasdaq: SLRN) is a Los Angeles area-based late-stage clinical biopharma company – with additional operations in the San Francisco Bay area – focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising product candidates.

ACELYRIN is embedding a corporate culture of Courageous Caring™ -- placing patients first and embracing the concept that all of us are better than any one of us -- as we seek to addresses the most basic human needs: to live a productive life free from diseases.

✕

Access Insights for ACELYRIN, INC. and Millions of Other Companies

Sign up for full access to ACELYRIN, INC. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
4149 Liberty Canyon Rd Agoura Hills, California 91301 US
Website
acelyrin.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
SLRN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $300M

    ACELYRIN, INC. has raised a total of $300M of funding over 3 rounds. Their latest funding round was raised on Sep 13, 2022 in the amount of $300M.

  • $10M$50M

    ACELYRIN, INC.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $300M

    ACELYRIN, INC. has raised a total of $300M of funding over 3 rounds. Their latest funding round was raised on Sep 13, 2022 in the amount of $300M.

  • $10M$50M

    ACELYRIN, INC.'s revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for ACELYRIN, INC. and Millions of Other Companies

Sign up for full access to ACELYRIN, INC. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.